J Rodés

9.8k total citations · 3 hit papers
187 papers, 6.9k citations indexed

About

J Rodés is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, J Rodés has authored 187 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Hepatology, 103 papers in Epidemiology and 37 papers in Surgery. Recurrent topics in J Rodés's work include Liver Disease and Transplantation (90 papers), Liver Disease Diagnosis and Treatment (89 papers) and Liver Diseases and Immunity (22 papers). J Rodés is often cited by papers focused on Liver Disease and Transplantation (90 papers), Liver Disease Diagnosis and Treatment (89 papers) and Liver Diseases and Immunity (22 papers). J Rodés collaborates with scholars based in Spain, United States and France. J Rodés's co-authors include Vicente Arroyo, Antoni Rimola, Jordi Bruix, Miquel Navasa, Juan Carlos García‐Pagán, Wladimiro Jiménez, Antoni Castells, Albert Parés, Josep Visa and Faust Feu and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

J Rodés

180 papers receiving 6.6k citations

Hit Papers

Surgical resection of hepatocellular carcinoma in cirrhot... 1988 2026 2000 2013 1996 2001 1988 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Rodés Spain 44 5.1k 4.2k 2.2k 573 526 187 6.9k
Laurence M. Blendis Canada 48 4.0k 0.8× 3.5k 0.8× 2.1k 0.9× 818 1.4× 403 0.8× 154 6.6k
M Pietroni United States 4 5.1k 1.0× 4.3k 1.0× 1.9k 0.8× 456 0.8× 275 0.5× 9 6.6k
I M Murray-Lyon United Kingdom 27 6.3k 1.2× 5.4k 1.3× 2.2k 1.0× 653 1.1× 514 1.0× 71 9.0k
Antoine Hadengue Switzerland 52 6.1k 1.2× 5.1k 1.2× 4.0k 1.8× 903 1.6× 533 1.0× 227 9.3k
Vı́ctor Vargas Spain 41 5.8k 1.2× 5.3k 1.2× 2.3k 1.0× 304 0.5× 362 0.7× 149 7.4k
J L Dawson United Kingdom 20 5.7k 1.1× 4.6k 1.1× 2.6k 1.2× 805 1.4× 309 0.6× 40 8.0k
Jaume Bosch Spain 54 8.1k 1.6× 6.9k 1.6× 4.2k 1.9× 543 0.9× 600 1.1× 156 9.9k
Elwyn Elias United Kingdom 52 4.6k 0.9× 3.6k 0.9× 3.0k 1.4× 786 1.4× 937 1.8× 229 8.5k
Telfer B. Reynolds United States 46 4.6k 0.9× 4.0k 1.0× 2.7k 1.2× 877 1.5× 393 0.7× 134 7.5k
Rafael Bañares Spain 50 6.9k 1.4× 6.3k 1.5× 3.9k 1.8× 487 0.8× 324 0.6× 256 8.9k

Countries citing papers authored by J Rodés

Since Specialization
Citations

This map shows the geographic impact of J Rodés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Rodés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Rodés more than expected).

Fields of papers citing papers by J Rodés

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Rodés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Rodés. The network helps show where J Rodés may publish in the future.

Co-authorship network of co-authors of J Rodés

This figure shows the co-authorship network connecting the top 25 collaborators of J Rodés. A scholar is included among the top collaborators of J Rodés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Rodés. J Rodés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortega, Rolando, Pere Ginès, B. Calahorra, et al.. (2002). Effects of terlipressin administration with and without albumin in hepatorenal syndrome (HRS). A phase II study. Journal of Hepatology. 36. 15–15. 10 indexed citations
2.
Colell, Anna, Carmen García‐Ruiz, Albert Morales, et al.. (1997). Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: Effect of membrane physical properties and S -adenosyl-L-methionine. Hepatology. 26(3). 699–708. 139 indexed citations
3.
Bruguera, Miquel, et al.. (1996). [The efficacy of excluding anti-HVC-positive donors by ELISA 2 in the prevention of posttransfusion hepatitis].. PubMed. 19(5). 240–2. 1 indexed citations
4.
Forns, Xavier, F. Xavier López‐Labrador, Sergi Ampurdanés, et al.. (1996). Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. Journal of Clinical Microbiology. 34(10). 2516–2521. 53 indexed citations
5.
Rimola, Antoni, Joan Manuel Salmerón, G. Clemente, et al.. (1995). Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study. Hepatology. 21(3). 674–679. 131 indexed citations
6.
Boix, Loreto, Antoni Castells, Jordi Bruix, et al.. (1995). Androgen receptors in hepatocellular carcinoma and surrounding liver: relationship with tumor size and recurrence rate after surgical resection. Journal of Hepatology. 22(6). 616–622. 31 indexed citations
7.
Pujol, A, Francesc Graus, A. Rimola, et al.. (1994). Predictive factors of in‐hospital CNS complications following liver transplantation. Neurology. 44(7). 1226–1226. 71 indexed citations
8.
Bruguera, Miquel, et al.. (1992). [A change in the epidemiologic pattern of hepatitis A in Spain].. PubMed. 99(3). 87–9. 23 indexed citations
9.
Bruix, Jordi, et al.. (1991). Tumor size determines the long-term efficacy of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC). Journal of Hepatology. 13. S15–S15. 14 indexed citations
10.
Luca, Annamaria De, et al.. (1991). Normalization of portal pressure (PP) following end-to-side portacaval shunt (PCS) worsens systemic hemodynamic abnormalities in cirrhosis. Journal of Hepatology. 13. S46–S46. 4 indexed citations
11.
Navasa, Miquel, J Chesta, Jaime Bosch, & J Rodés. (1989). Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Gastroenterology. 96(4). 1110–1118. 126 indexed citations
12.
Calvopina, Diego A., et al.. (1988). Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy. Journal of Hepatology. 7(1). 106–110. 26 indexed citations
13.
Sánchez–Tapias, José M., Albert Mas, Josep Costa, et al.. (1987). Recombinant α2c-interferon therapy in fulminant viral hepatitis. Journal of Hepatology. 5(2). 205–210. 27 indexed citations
14.
Neuberger, James, Erik Christensen, Bernard Portmann, et al.. (1985). Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.. Gut. 26(2). 114–119. 71 indexed citations
15.
Lamar, Carlos, et al.. (1982). Ground glass inclusions in hepatocytes of patients on alcohol aversion therapy. Hepatology. 2(5). 682. 5 indexed citations
16.
Caballería, Joan, et al.. (1980). [Epidemiology of hepatitis B in hospital personnel (author's transl)].. PubMed. 74(1). 1–4. 3 indexed citations
17.
Terés, J, et al.. (1976). Upper gastrointestinal bleeding in cirrhosis: clinical and endoscopic correlations.. Gut. 17(1). 37–40. 60 indexed citations
18.
Mas, Antoni, Vicente Arroyo, J Rodés, & J. Bosch. (1975). Ascites and renal failure in primary liver cell carcinoma.. BMJ. 3(5984). 629.1–629. 5 indexed citations
19.
Bruguera, Miguel, Jaime Bosch, J Rodés, & J. Pedreira. (1974). Familial Clustering of Hepatitis B Antigen: A Study in Relatives of Patients with Liver Diseases and Hepatitis B Antigenaemia. BMJ. 3(5929). 495–497. 14 indexed citations
20.
Bruguera, Miguel, Jordi Bosch, & J Rodés. (1973). Family outbreak of hepatitis B.. New England Journal of Medicine. 289(21). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026